{"result": "(\"entity\"<|>HOMBRES<|>PERSON<|>Hombres are mentioned in the context of being affected by adrenal conditions, with a specific prevalence rate compared to women.)\n##\n(\"entity\"<|>MUJERES<|>PERSON<|>Mujeres are mentioned as being more frequently affected by adrenal conditions compared to hombres.)\n##\n(\"entity\"<|>ENFERMEDAD LOCALIZADA<|>EVENT<|>Enfermedad localizada refers to a condition where the disease is confined to a specific area, which may be treated surgically.)\n##\n(\"entity\"<|>HIPOGLANDULARISMO<|>EVENT<|>Hipoglandularismo is a condition associated with reduced hormone production, which can occur as a side effect of treatments like mitotano.)\n##\n(\"entity\"<|>CORTEX SUPRARRENAL<|>GEO<|>Cortex suprarrenal refers to the outer layer of the adrenal glands, which is involved in hormone production and is affected by conditions like carcinoma.)\n##\n(\"entity\"<|>GLUCOCORTICOIDES<|>ORGANIZATION<|>Glucocorticoides are a type of steroid hormone produced by the adrenal cortex, often involved in the treatment of adrenal disorders.)\n##\n(\"entity\"<|>HORMONAS SEXUALES<|>ORGANIZATION<|>Hormonas sexuales are sex hormones that can be influenced by treatments affecting adrenal function, such as mitotano.)\n##\n(\"entity\"<|>INSUFICIENCIA SUPRARRENAL<|>EVENT<|>Insuficiencia suprarrenal is a condition where the adrenal glands do not produce sufficient hormones, which may require treatment adjustments when using mitotano.)\n##\n(\"entity\"<|>KI67<|>PERSON<|>Ki67 is a protein used as a marker for cell proliferation, relevant in assessing the risk of recurrence in adrenal carcinoma patients.)\n##\n(\"entity\"<|>TUMORES<|>EVENT<|>Tumores refer to abnormal growths that can occur in the adrenal glands, some of which may be functional and produce hormones.)\n##\n(\"entity\"<|>CORTISOL<|>ORGANIZATION<|>Cortisol is a hormone produced by the adrenal glands that is involved in various bodily functions and can be affected by treatments like mitotano.)\n##\n(\"entity\"<|>REFERENCIAS<|>EVENT<|>Referencias are citations provided in the text that support the information regarding treatments and conditions related to adrenal health.)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: Las mujeres suelen verse afectadas                 con más      frecuencia que los                     andrógenos (10%).\n              hombres (2,5:1). La media de edad del comienzo es de 40 a 50 años, aunque los hombres                                                La cirugía ofrece la única opción de curación a los pacientes con enfermedad localizada.\n              tienden a una mayor edad en el momento del diagnóstico. El 80% de los tumores son fun-\n              cionales, y lo más frecuente es que segreguen glucocorticoides solamente (45%), glucocor-                                            El mitotano está indicado en ficha técnica para el tratamiento sintomático del carcinoma\n              ticoides y andrógenos (45%) o solo andrógenos (10%). La cirugía ofrece la única opción de                                            avanzado de la corteza suprarrenal inextirpable, metastásico o recidivante. También se\n              curación a los pacientes con enfermedad localizada.                                                                                  ha sugerido su utilización como tratamiento adyuvante a la cirugía en pacientes con alto\n              El mitotano está indicado en ficha técnica para el tratamiento sintomático del carcinoma                                             riesgo de recurrencia (histología con un alto grado proliferativo valorado por Ki67 > 10%; o\n              avanzado      de   la corteza suprarrenal inextirpable, metastásico o recidivante. El mitota-                                        más de 20 mitosis por 50 campos), rotura del tumor intraoperatoria y algunos tumores de\n                                                                                                                                                   gran tamaño y bajo grado histológico, pero con invasión capsular o vascular.\n              no tiene actividad citotóxica sobre la corteza suprarrenal, pero también puede causar una\n              inhibición suprarrenal sin destrucción celular, e induce un estado de insuficiencia supra-                                           El mitotano tiene actividad citotóxica sobre la corteza suprarrenal, aunque al parecer tam-\n              rrenal que deberá ser tratada y que puede precisar dosis de sustitución de glucocorticoi-                                            bién puede causar inhibición suprarrenal sin destrucción celular, e induce un estado de\n              des más altas de lo habitual por el efecto sobre el metabolismo periférico del cortisol. Se                                          insuficiencia suprarrenal que deberá ser tratada y que puede precisar dosis de sustitución\n              considera que la zona glomerular, responsable de la síntesis de los mineralocorticoides,                                             de glucocorticoides más altas de lo habitual por el efecto sobre el metabolismo periférico\n              es más resistente al efecto adrenolítico del mitotano. La administración de mitotano se                                              del cortisol.\n              debe interrumpir de inmediato y temporalmente después de un shock, traumatismo grave                                                 Se considera que la zona glomerular, responsable de la síntesis de los mineralocorticoides,\n              o infección, ya que su principal acción es la supresión suprarrenal.                                                                 es más resistente al efecto adrenolítico del mitotano.\n              Se ha demostrado que el mitotano aumenta los niveles en plasma de la proteína transpor-                                              Referencias:\n              tadora de hormonas sexuales de unión a hormonas (SHBG) y de la globulina transportadora                                              • Lacroix A, Hammer GD. Treatment of adrenocortical carcinoma. UpToDate. Waltham, MA: UpToDate Inc. https://www.uptodate.com.\n              del cortisol (CBG). Esto se debe tener en cuenta cuando se interpreten los resultados de las                                           Literature review current through: Apr. 2019.\n                                                                                                                                                   • Steward PM, Newell-Price JDC. The adrenal cortex. En: Melmed S, Polonsky KS, Larsen PR, Kronenberg HM, eds. Williams Textbook\n              pruebas hormonales. En los             varones, el hipogonadismo asociado                 al tratamiento con el                        of Endocrinology. 13.ª ed. Philadelphia: Elsevier; 2016. p. 490-555.\n              mitotano es común y frecuentemente precisa tratamiento sustitutivo con testosterona.\n              Referencias:\n              • Lacroix A, Hammer GD. Treatment of adrenocortical carcinoma. UpToDate. Waltham, MA: UpToDate Inc. https://www.uptodate.com.\n                Literature review current through: Apr. 2019.\n              • Steward PM, Newell-Price JDC. The adrenal cortex. En: Melmed S, Polonsky KS, Larsen PR, Kronenberg HM, eds. Williams Textbook\n                of Endocrinology. 13.ª ed. Philadelphia: Elsevier; 2016. p. 490-555.\n\n\n\n296                                                                                                                                                                                                                                                                         297\n---\n                                                                                                                                                                                                                        SUPRARRENALES                 5\n\n\n\n     42  Indique qué es falso en el carcinoma suprarrenal:                                                                                5.7 Hiperplasia suprarrenal congénita\n         A. Son más frecuentes en mujeres.\n         B. Son más frecuentes los tumores con aumento de la producción hormonal.                                                                   Con respecto al manejo de las mujeres con hiperplasia suprarrenal congénita por\n         C. Cuando tienen producción hormonal, de más frecuente a menos frecuente\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>MITOTANO<|>ORGANIZATION<|>Mitotano is a medication indicated for the symptomatic treatment of advanced adrenal cortex carcinoma and is used in various treatment scenarios for adrenal insufficiency.)\n##\n(\"entity\"<|>ADRENOCORTICAL CARCINOMA<|>EVENT<|>Adrenocortical carcinoma is a type of cancer affecting the adrenal cortex, which may require treatments such as surgery and medication like mitotano.)\n##\n(\"entity\"<|>HORMONAL TESTS<|>EVENT<|>Hormonal tests are conducted to evaluate the levels of various hormones in the body, which can be affected by treatments like mitotano.)\n##\n(\"entity\"<|>GLUCOCORTICOIDS<|>ORGANIZATION<|>Glucocorticoids are a class of steroid hormones that are often involved in the treatment of various conditions, including those related to adrenal function.)\n##\n(\"entity\"<|>SUPRARENAL GLAND<|>GEO<|>The suprarenal glands, also known as adrenal glands, are located above the kidneys and are responsible for producing hormones such as glucocorticoids.)\n##\n(\"entity\"<|>LACROIX A<|>PERSON<|>Lacroix A is an author referenced in the literature regarding the treatment of adrenocortical carcinoma.)\n##\n(\"entity\"<|>STEWARD PM<|>PERSON<|>Steward PM is another author referenced in the literature regarding the adrenal cortex and its functions.)\n##\n(\"relationship\"<|>MITOTANO<|>ADRENOCORTICAL CARCINOMA<|>Mitotano is used for the treatment of advanced adrenocortical carcinoma, making it a relevant medication for this condition.<|>8)\n##\n(\"relationship\"<|>SUPRARENAL GLAND<|>MITOTANO<|>Mitotano affects the function of the suprarenal glands by suppressing adrenal activity, which is crucial in the context of adrenal disorders.<|>7)\n##\n(\"relationship\"<|>HORMONAL TESTS<|>MITOTANO<|>Hormonal tests are important for monitoring the effects of mitotano on hormone levels in patients undergoing treatment for adrenal conditions.<|>6)\n##\n(\"relationship\"<|>LACROIX A<|>ADRENOCORTICAL CARCINOMA<|>Lacroix A is cited in literature discussing the treatment protocols for adrenocortical carcinoma, indicating a professional connection to the topic.<|>5)\n##\n(\"relationship\"<|>STEWARD PM<|>SUPRARENAL GLAND<|>Steward PM is referenced in literature that discusses the functions and disorders of the adrenal glands, linking him to the study of adrenal health.<|>5)\n<|COMPLETE|>"}]}